Aim: To evaluate salivary C-reactive protein (CRP) levels in children with skeletal class II malocclusion and with a positive history of sleep disorders.
Materials and methods: Twenty-one children aged 8–12 years with skeletal class II malocclusion and at least one sleep disorder participated in the study (group I). Twenty-one age and gender-matched children with no skeletal malocclusion and no reported history of sleep disorders served as a comparison group (group II). All children were evaluated regarding their sleep history and clinically examined to determine craniofacial morphology. Children of group I were subjected to a radiographic assessment including evaluation of airway space. Unstimulated saliva was collected from all children. Salivary CRP was measured using CRP LEIT kit (Agappe) with calibrator, which is a latex-enhanced turbidimetric immunoassay. Statistical analysis for intergroup comparison (two groups) for normally distributed data was done using t-test.
Results: There was a significantly higher level of salivary CRP, in children of group I when compared to that of group II children (p < 0.01).
Conclusion: Salivary CRP may be a simple and noninvasive tool in the identification and screening of children at high risk for sleep disorders.
Clinical significance: Routine salivary CRP monitoring could be a valuable biomarker in early recognition and treatment sleep disorders in children.
Asker S, Asker M, Sarikaya E, et al. Oxidative stress parameters and their correlation with clinical, metabolic and polysomnographic parameters in severe obstructive sleep apnea syndrome. Int J Clin Exp Med 2015;8(7):11449–11455.
Gozal D. Sleep, sleep disorders and inflammation in children. Sleep Med 2009;10(Suppl 1):S12–S16. DOI: 10.1016/j.sleep.2009.07.003
Takahashi Y, Kipnis DM, Daughaday WH. Growth hormone secretion during sleep. J Clin Investig 1968;47(9):2079–2090. DOI: 10.1172/JCI105893
Dahl R. The impact of inadequate sleep on children's daytime cognitive function. Semin Pediatr Neurol 1996;3(1):44–50. DOI: 10.1016/s1071-9091(96)80028-3
Gozal D. Sleep-disordered breathing and school performance in children. Pediatrics 1998;102(3):616–620. DOI: 10.1542/peds.102.3.616
Archontogeorgis K, Nena E, Papanas N, et al. Biomarkers to improve diagnosis and monitoring of obstructive sleep apnea syndrome: current status and future perspectives. Pulm Med 2014;2014:930535. DOI: 10.1155/2014/930535
Marcus CL, Brooks LJ, Ward SD, et al. Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics 2012;130(3):e714–e755. DOI: 10.1542/peds.2012-1672
Spruyt K, Gozal D. Screening of Pediatric sleep-disordered breathing: a proposed unbiased discriminative set of questions using clinical severity scales. Chest 2012;142(6):1508–1515. DOI: 10.1378/chest.11-3164
Gozal D. Serum, urine, and breath-related biomarkers in the diagnosis of obstructive sleep apnea in children: is it for real? Curr Opin Pulm Med 2012;18(6):561–567. DOI: 10.1097/MCP.0b013e328358be2d
Lamm C, Mandeli J, Kattan M. Evaluation of home audiotapes as an abbreviated test for obstructive sleep apnea syndrome (OSAS) in children. Pediatr Pulmonol 1999;27(4):267–272. DOI: 10.1002/(sici) 1099-0496(199904)27:4<267::aid-ppul7>3.0.co;2-x
Sivan Y, Kornecki A, Schonfeld T. Screening obstructive sleep apnoea syndrome by home videotape recording in children. Eur Respir J 1996;9(10):2127–2131. DOI: 10.1183/09031936.96.09102127
Brouillette RT, Morielli A, Leimanis A, et al. Nocturnal pulse oximetry as an abbreviated testing modality for pediatric obstructive sleep apnea. Pediatrics 2000;105(2):405–412. DOI: 10.1542/peds.105.2.405
Andreu AL, Chiner E, Sancho-Chust JN, et al. Effect of an ambulatory diagnostic and treatment programme in patients with sleep apnoea. Eur Respir J 2012;39(2):305–312. DOI: 10.1183/09031936.00013311
Peker Y, Hedner J, Norum J, et al. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med 2002;166(2):159–165. DOI: 10.1164/rccm.2105124
Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340(6):448–454. DOI: 10.1056/NEJM199902113400607
Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol 2018;9:754. DOI: 10.3389/fimmu.2018.00754
Li K, Wei P, Qin Y, et al. Is C-reactive protein a marker of obstructive sleep apnea?: a meta-analysis. Medicine 2017;96(19):e6850. DOI: 10.1097/MD.0000000000006850
Meier-Ewert HK, Ridker PM, Rifai N, et al. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 2004;43(4):678–683. DOI: 10.1016/j.jacc.2003.07.050
Huynh NT, Morton PD, Rompre PH, et al. Associations between sleep-disordered breathing symptoms and facial and dental morphometry, assessed with screening examinations. Am J Orthod Dentofacial Orthop 2011;140(6):762–770. DOI: 10.1016/j.ajodo.2011.03.023
Kim J, Bhattacharjee R, Dayyat E, et al. Increased cellular proliferation and inflammatory cytokines in tonsils derived from children with obstructive sleep apnea. Pediatr Res 2009;66(4):423–428. DOI: 10.1203/PDR.0b013e3181b453e3
Anusha Y, Shetty V, Hegde AM. Correlation of nutritional status to sleep problems in school going children: a preliminary study. Indian J Sleep Med 2018;13(1):1–4. DOI: 10.5005/jp-journals-10069-0015
Patacchioli FR, Tabarrini A, Ghiciuc CM, et al. Salivary biomarkers of obstructive sleep apnea syndrome in children. Pediatr Pulmonol 2014;49(11):1145–1152. DOI: 10.1002/ppul.22972
Katyal V, Pamula Y, Daynes CN, et al. Craniofacial and upper airway morphology in pediatric sleep-disordered breathing and changes in quality of life with rapid maxillary expansion. Am J Orthod Dentofacial Orthop 2013;144(6):860–871. DOI: 10.1016/j.ajodo.2013.08.015
Yamuna Priya K, Muthu Prathibha K. Methods of collection of saliva—a review. Int J Oral Health Dent 2017;3(3):149–148. DOI: 10.18231/2395-499X.2017.0032
Zeigenhagen G, Drahovshy D. Klinishe Bedeutung des C-reaktive protein. Med klin 1983;78:45–50.
Tauman R, Ivanenko A, O'Brien LM, et al. Plasma C-reactive protein levels among children with sleep-disordered breathing. Pediatrics 2004;113(6):e564–e569.
Larkin EK, Rosen CL, Kirchner HL, et al. Variation of C-reactive protein levels in adolescents: association with sleep-disordered breathing and sleep duration. Circulation 2005;111(15):1978–1984. DOI: 10.1161/01.CIR.0000161819.76138.5E
Kaditis AG, Alexopoulos EI, Kalampouka E, et al. Morning levels of C-reactive protein in children with obstructive sleep-disordered breathing. Am J Respir Crit Care Med 2005;171(3):282–286. DOI: 10.1164/rccm.200407-928OC
Cao Y, Song Y, Ning P, et al. Association between tumor necrosis factor alpha and obstructive sleep apnea in adults: a meta-analysis update. BMC Pulm Med 2020;20(1):1–7. DOI: 10.1186/s12890-020-01253-0
Gozal D, Kheirandish-Gozal L, Bhattacharjee R, et al. C-reactive protein and obstructive sleep apnea syndrome in children. Front Biosci (Elite Ed) 2012;4(7):2410–2422. DOI: 10.2741/e553
Hirshkowitz M, Whiton K, Albert SM, et al. National Sleep Foundation's sleep time duration recommendations: methodology and results summary. Sleep Health 2015;1(1):40–43. DOI: 10.1016/j.sleh.2014.12.010
Dzierzewski JM, Donovan EK, Kay DB, et al. Sleep inconsistency and markers of inflammation. Front Neurol 2020;11:1042. DOI: 10.3389/fneur.2020.01042
Ingram DG, Matthews CK. Effect of adenotonsillectomy on C-reactive protein levels in children with obstructive sleep apnea: a meta-analysis. Sleep Med 2013;14(2):172–176. DOI: 10.1016/j.sleep.2012.11.011